title: Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.
abstract: Medulloblastoma spreads by leptomeningeal dissemination rather than by infiltration that characterizes other CNS tumors, eg, gliomas. This study represents an initial attempt to identify both the molecules that mediate medulloblastoma adhesion to leptomeninges and the pathways that are key to survival and proliferation of tumor following adhesion. As a first step in molecule identification, we produced adhesion of D283 medulloblastoma cells to the extracellular matrix (ECM) of H4 glioma cells in vitro. Within this context, D283 cells preferentially expressed the alpha9 and beta1 integrin subunits; antibody and disintegrin blockade of alpha9 and beta1 binding eliminated the adhesion. The H4 ECM was enriched in tenascin, a binding partner for the alpha9beta1 integrin heterodimer. Purified tenascin-C supported D283 cell adhesion. The adhesion was blocked by antibodies to alpha9 and beta1 integrin. In vivo data were similar; immunohistochemistry of primary human medulloblastomas with leptomeningeal extension demonstrated increased expression of alpha9 and beta1 integrins as well as tenascin at the interface of brain and leptomeningeal tumor. These data suggest that tumor-cell expressions of alpha9 and beta1 integrins in combination with extracellular tenascin are necessary for medulloblastoma adhesion to the leptomeninges. As a first step in the identification of pathways that mediate survival and proliferation of tumor following adhesion, we demonstrated that adhesion to H4 ECM was associated with survival and proliferation of D283 cells as well as activation of the MAPK pathway in a growth factor deficient environment. Antibody blockade of alpha9 and beta1 integrin binding that eliminated adhesion also eliminated the in vitro survival benefit. These data suggest that adhesion of medulloblastoma to the meninges is necessary for the survival and proliferation of these tumor cells at the secondary site.
authors.affiliation: Department of Neuroscience and Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Fiorilli
authors.forename: Darren
authors.initials: D
authors.lastname: Partridge
authors.forename: Izabela
authors.initials: I
authors.lastname: Staniszewska
authors.forename: Jin Y
authors.initials: JY
authors.lastname: Wang
authors.forename: Maja
authors.initials: M
authors.lastname: Grabacka
authors.forename: Kelvin
authors.initials: K
authors.lastname: So
authors.forename: Cezary
authors.initials: C
authors.lastname: Marcinkiewicz
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Reiss
authors.forename: Kamel
authors.initials: K
authors.lastname: Khalili
authors.forename: Sidney E
authors.initials: SE
authors.lastname: Croul
mesh_terms: D002448:Cell Adhesion / Q000502:physiology*; D045744:Cell Line, Tumor; D003598:Cytoskeletal Proteins / Q000502:physiology; D005109:Extracellular Matrix / Q000502:physiology; D006801:Humans; D016023:Integrins / Q000502:physiology*; D008527:Medulloblastoma / Q000503:physiopathology*; D008577:Meningeal Neoplasms / Q000503:physiopathology*; D009362:Neoplasm Metastasis / Q000503:physiopathology; D019063:Tenascin / Q000502:physiology*
chemical_list: C088832:CCDC6 protein, human; D003598:Cytoskeletal Proteins; D016023:Integrins; D019063:Tenascin; C113256:integrin alpha 9 beta 1
references.citation: Int J Cancer. 1997 Jul 3;72(1):77-86
references.pmid: 9212227
references.citation: Exp Neurol. 1991 Feb;111(2):152-65
references.pmid: 1703496
references.citation: Invest Ophthalmol Vis Sci. 1988 Jul;29(7):1141-50
references.pmid: 3047074
references.citation: Ultrastruct Pathol. 1995 May-Jun;19(3):147-66
references.pmid: 7631430
references.citation: Am J Pathol. 1999 May;154(5):1525-37
references.pmid: 10329605
references.citation: Oncologist. 2003;8(2):174-86
references.pmid: 12697942
references.citation: Biochem J. 1996 Aug 1;317 ( Pt 3):817-25
references.pmid: 8760368
references.citation: Clin Cancer Res. 2001 Aug;7(8):2425-33
references.pmid: 11489822
references.citation: J Cell Biol. 2001 Apr 16;153(2):273-82
references.pmid: 11309409
references.citation: Dev Dyn. 1995 May;203(1):71-9
references.pmid: 7544171
references.citation: J Immunol. 2002 Jan 15;168(2):696-704
references.pmid: 11777963
references.citation: Acta Neuropathol. 1991;83(1):46-54
references.pmid: 1665274
references.citation: Nat Genet. 2001 Oct;29(2):143-52
references.pmid: 11544480
references.citation: J Clin Oncol. 2006 Mar 10;24(8):1253-65
references.pmid: 16525180
references.citation: J Clin Endocrinol Metab. 1993 Nov;77(5):1113-9
references.pmid: 7521338
references.citation: Glia. 1999 Mar;26(1):36-46
references.pmid: 10088670
references.citation: Cancer Res. 1990 Oct 1;50(19):6364-70
references.pmid: 2400996
references.citation: J Clin Oncol. 1999 Mar;17(3):832-45
references.pmid: 10071274
references.citation: J Cell Biol. 1993 Dec;123(5):1289-97
references.pmid: 8245132
references.citation: Cancer Res. 2003 Jan 1;63(1):140-8
references.pmid: 12517790
references.citation: Endocrinology. 2003 Apr;144(4):1486-95
references.pmid: 12639933
references.citation: Int J Cancer. 1997 Sep 17;72(6):1034-44
references.pmid: 9378538
references.citation: Am J Pathol. 2001 Dec;159(6):2071-80
references.pmid: 11733357
references.citation: Mol Biol Cell. 2000 Jul;11(7):2235-49
references.pmid: 10888665
references.citation: Am J Pathol. 1989 Jul;135(1):161-8
references.pmid: 2528301
references.citation: J Comp Neurol. 1994 Feb 8;340(2):233-42
references.pmid: 7515397
references.citation: Lab Invest. 2002 Nov;82(11):1493-502
references.pmid: 12429809
references.citation: Brain Res. 1998 May 18;793(1-2):328-32
references.pmid: 9630708
references.citation: Br J Cancer Suppl. 1991 Jun;14:20-3
references.pmid: 2039710
references.citation: Can J Neurol Sci. 1987 Feb;14(1):25-30
references.pmid: 3028590
references.citation: J Neurooncol. 1998 Jun-Jul;38(2-3):97-102
references.pmid: 9696358
references.citation: Nature. 2002 Jan 24;415(6870):436-42
references.pmid: 11807556
references.citation: Nat Rev Cancer. 2005 Jan;5(1):51-63
references.pmid: 15630415
references.citation: Neurol Med Chir (Tokyo). 2004 Aug;44(8):402-6; discussion 407
references.pmid: 15508347
references.citation: J Neurosci Res. 1990 Oct;27(2):169-83
references.pmid: 2254962
references.citation: Biochemistry. 2004 Feb 17;43(6):1639-47
references.pmid: 14769041
references.citation: J Neuropathol Exp Neurol. 1987 Nov;46(6):623-33
references.pmid: 3655835
references.citation: J Biol Chem. 2000 Oct 13;275(41):31930-7
references.pmid: 10926928
references.citation: Bioessays. 2000 Sep;22(9):818-26
references.pmid: 10944584
references.citation: Neurosurgery. 1987 Dec;21(6):872-8
references.pmid: 3437956
references.citation: Kurume Med J. 2002;49(4):177-83
references.pmid: 12652968
references.citation: Biochim Biophys Acta. 2007 Jan;1775(1):163-80
references.pmid: 17084981
references.citation: Neuropathol Appl Neurobiol. 1999 Jun;25(3):207-14
references.pmid: 10417662
references.citation: J Neurosci Methods. 2007 Jun 15;163(1):76-82
references.pmid: 17403541
references.citation: Acta Neuropathol. 2007 Nov;114(5):459-69
references.pmid: 17687559
references.citation: Neurol Res. 1995 Feb;17(1):49-58
references.pmid: 7746343
references.citation: Annu Rev Neurosci. 2003;26:207-38
references.pmid: 12598678
references.citation: Oncogene. 2006 Mar 2;25(9):1378-90
references.pmid: 16247454
references.citation: J Neurosurg. 1988 Aug;69(2):155-70
references.pmid: 3292716
references.citation: Lab Invest. 1986 Jul;55(1):71-85
references.pmid: 3724065
references.citation: Proc Natl Acad Sci U S A. 1979 Apr;76(4):1882-6
references.pmid: 377289
references.citation: Cancer Res. 1987 Jul 1;47(13):3515-22
references.pmid: 3555773
references.citation: J Neurosci. 1987 Oct;7(10):3325-33
references.pmid: 3668630
references.citation: Acta Neurochir (Wien). 2001 Aug;143(8):811-8; discussion 819
references.pmid: 11678402
references.citation: J Neuropathol Exp Neurol. 1986 May;45(3):285-303
references.pmid: 3083053
references.citation: Pathol Int. 2003 Feb;53(2):67-73
references.pmid: 12588433
references.citation: Curr Opin Cell Biol. 2003 Oct;15(5):621-32
references.pmid: 14519398
references.citation: Acta Neuropathol. 1991;82(1):45-54
references.pmid: 1659106
references.citation: Dev Dyn. 1993 May;197(1):40-56
references.pmid: 8400410
references.citation: Invasion Metastasis. 1991;11(6):310-24
references.pmid: 1822845